Table 1.
Clinical and histopathological characteristics of the study group.
| N = 100 (%) | ||
|---|---|---|
| Age (mean, ys) | 63.8 | |
| Female/Male | 37 (37)/63(63) | |
| Type of surgery (N, %) | ||
| D2 total gastrectomy | 69 (69) | |
| D2 extended total gastrectomy | 4 (4) | |
| Subtotal resection | 4 (4) | |
| Laparotomy/gastric bypass | 23 (23) | |
| Radicality of resection (N, %) | ||
| R0 resection | 68 (68) | |
| R1 resection | 8 (8) | |
| R2 resection | 1(1) | |
| Cancer location (N, %) | ||
| Proximal part of stomach (the cardia and/or bottom of stomach) | 22 (22) | |
| Distal part (body and/or prepyloric region) | 64(64) | |
| Entire stomach | 14(14) | |
| Degree of histological malignancy (N, %) | ||
| G1 | 5 (5) | |
| G2 | 32 (32) | |
| G3 | 63(63) | |
| Type of Gastric Cancer according to Lauren Classification (17) | ||
| Intestinal | 43 (43) | |
| Diffuse | 44 (44) | |
| Mixed | 13(13) | |
| Stage of cancer (TNM) (4) | I | 15(15) |
| IIA | 16 (16) | |
| IIB | 10 (10) | |
| IIIA | 14 (14) | |
| IIIB | 18 (18) | |
| IIIC | 6 (6) | |
| IV | 21(21) | |
| T parameter | ||
| T1 | 10 (10) | |
| T2 | 13 (13) | |
| T3 | 43 (43) | |
| T4a | 26(26) | |
| T4b | 8 (8) | |
| N parameter | ||
| N+ | 66 (66) | |
| N- | 34 (34) | |
| Macroscopically visible peritoneal/organ dissemination | M1 | 21 (21) |
| Perioperative/postoperative treatment | Perioperative chemotherapy | 36 (36) |
| Postoperative chemotherapy | 22 (2) | |
| Palliative chemotherapy | 18 (18) | |